The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID‐19 infection
Open Access
- 10 June 2021
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 9 (6) , e04347
Abstract
Owing to autoantibody production and thrombophilic disorders in COVID‐19, physicians must have low threshold to investigate secondary IIH and demyelinating disorders in patients with headache and decreased vision following recent COVID‐19 infection.Keywords
This publication has 28 references indexed in Scilit:
- Miller Fisher syndrome and polyneuritis cranialis in COVID-19Neurology, 2020
- Extrapulmonary manifestations of COVID-19Nature Medicine, 2020
- Neurological manifestations of COVID-19 and other coronavirus infections: A systematic reviewClinical Neurology and Neurosurgery, 2020
- Guillain–Barré Syndrome Associated with SARS-CoV-2New England Journal of Medicine, 2020
- COVID-19 and Kawasaki Disease: Novel Virus and Novel CaseHospital Pediatrics, 2020
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19New England Journal of Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patientsJournal of Medical Virology, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationJournal of Neurology, Neurosurgery & Psychiatry, 2017